aflo

aflo automates inhaler techniques to improve the management of respiratory conditions.

Health and bio

aflo raised $1.2M in a Pre Seed round announced September 23, 2026, according to syncni.com. Investors in that round: Angel Academe, QUBIS, SyndicateRoom.

Founders and team

• JH
  Jim Harkin Founder

  source: crunchbase.com
• LM
  Liam McDaid Founder

  source: crunchbase.com
• SK
  Susan Kelly Founder

  source: crunchbase.com

Raise history

1. September 23, 2026
   Pre Seed · $1.2M
   AAngel Academe (lead), QQUBIS, SSyndicateRoom
   Source: syncni.com
2. March 29, 2021
   X account created

Investors

• AAngel Academe
• QQUBIS
• SSyndicateRoom

Related bio health companies

• SSharp$328K · Oct 1, 2026
• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/aflo.